相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Repurposing of plant alkaloids for cancer therapy: Pharmacology and toxicology
Thomas Efferth et al.
SEMINARS IN CANCER BIOLOGY (2021)
Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro
Ridhima Wadhwa et al.
JOURNAL OF FOOD BIOCHEMISTRY (2021)
The Potential for Phospholipids in the Treatment of Airway Inflamma-tion: An Unexplored Solution
Varsha Komalla et al.
CURRENT MOLECULAR PHARMACOLOGY (2021)
Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes
Vineela Parvathaneni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC)
Suyash M. Patil et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Recent trends of NFkB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases
Meenu Mehta et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
Keshav Raj Paudel et al.
LIFE SCIENCES (2021)
Enhancing the in vitro and in vivo activity of itraconazole against breast cancer using miltefosine-modified lipid nanocapsules
Nabila A. El-Sheridy et al.
DRUG DELIVERY (2021)
Design, optimization, characterization, and in vivo evaluation of sterosomes as a carrier of metformin for treatment of lung cancer
Hasnaa Osama et al.
JOURNAL OF LIPOSOME RESEARCH (2020)
Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics
Bhuvaneshwar Vaidya et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Glutathione-responsive biodegradable polyurethane nanoparticles for lung cancer treatment
Roshni Iyer et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC)
Vineela Parvathaneni et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Bronchoscopic intratumoural therapies for non-small cell lung cancer
Andrew DeMaio et al.
EUROPEAN RESPIRATORY REVIEW (2020)
Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy
Eupa Ray et al.
AAPS PHARMSCITECH (2020)
Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinic et al.
DRUG RESISTANCE UPDATES (2020)
Evaluation of the In Vitro Stability of Stimuli-Sensitive Fatty Acid-Based Microparticles for the Treatment of Lung Cancer
Paulina Dalek et al.
LANGMUIR (2020)
Inhaled RNA Therapy: From Promise to Reality
Michael Y. T. Chow et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549
Neeta Solanki et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Development and validation of RP-HPLC method for simultaneous estimation of docetaxel and ritonavir in PLGA nanoparticles
P. S. Kumbhar et al.
ANNALES PHARMACEUTIQUES FRANCAISES (2020)
Overcoming the legal and regulatory barriers to drug repurposing
Alasdair Breckenridge et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
A perspective on magnetic core-shell carriers for responsive and targeted drug delivery systems
Kholoud E. Albinali et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Proliferation and Migration of Lung Cancer Could be Inhibited by Oxymatrine through the Regulation for miR-520/VEGF
Wen Zhou et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2019)
Hyaluronic acid - dihydroartemisinin conjugate: Synthesis, characterization and in vitro evaluation in lung cancer cells
Robin Kumar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling
Chi-Chuan Lin et al.
CANCER LETTERS (2019)
Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
Andrea Emanuele Guerini et al.
CANCERS (2019)
Impact of drug particle shape on permeability and cellular uptake in the lung
S. Zellnitz et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Repurposing Itraconazole Loaded PLGA Nanoparticles for Improved Antitumor Efficacy in Non-Small Cell Lung Cancers
Nabil A. Alhakamy et al.
PHARMACEUTICS (2019)
Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16
Priyanka Upadhyay et al.
BIOMATERIALS SCIENCE (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Antibiotic bedaquiline effectively targets growth, survival and tumor angiogenesis of lung cancer through suppressing energy metabolism
Xiaomu Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Current approaches to the discovery of novel inhaled medicines
Peter Strong et al.
DRUG DISCOVERY TODAY (2018)
Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs
Per Backman et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies
Nashwa Osman et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
Kalayanee Chairat et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Preparation, evaluation and pharmacokinetic studies of spray dried PLGA polymeric submicron particles of simvastatin for the effective treatment of breast cancer
Naqueeb Anzar et al.
JOURNAL OF MOLECULAR LIQUIDS (2018)
Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers
Tongtong Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
The potential to treat lung cancer via inhalation of repurposed drugs
Wing-Hin Lee et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Inhalational supplementation of metformin butyrate: A strategy for prevention and cure of various pulmonary disorders
Kunal Maniar et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Imidazole Antifungal Drugs Inhibit the Cell Proliferation and Invasion of Human Breast Cancer Cells
Sung Hun Bae et al.
BIOMOLECULES & THERAPEUTICS (2018)
Review of Drug Repositioning Approaches and Resources
Hanqing Xue et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and-9
Huai-Lu Chang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Comorbidities in the management of patients with lung cancer
Charlotte Leduc et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer
Chenhui Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Sanguinarine exhibits antitumor activity via up-regulation of Fas-associated factor 1 in non-small cell lung cancer
Guangxia Wei et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2017)
Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens
Lan Wu et al.
JOURNAL OF CONTROLLED RELEASE (2017)
The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer
Linh N. K. Tran et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
Repurposing itraconazole as an anticancer agent
Hiroshi Tsubamoto et al.
ONCOLOGY LETTERS (2017)
Targeting ALK: Precision Medicine Takes on Drug Resistance
Jessica J. Lin et al.
CANCER DISCOVERY (2017)
Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
Rafael Rios-Tamayo et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Design and Characterization of a Therapeutic Non-phospholipid Liposomal Nanocarrier with Osteoinductive Characteristics To Promote Bone Formation
Zhong-Kai Cui et al.
ACS NANO (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Drug delivery to the lungs: challenges and opportunities
Stephen P. Newman
THERAPEUTIC DELIVERY (2017)
Antitumor activity of intratracheal inhalation of temozolomide (TMZ) loaded into gold nanoparticles and/or liposomes against urethane-induced lung cancer in BALB/c mice
Mohamed A. Hamzawy et al.
DRUG DELIVERY (2017)
Loco-regional administration of nanomedicines for the treatment of lung cancer
Gabriela Garrastazu Pereira et al.
DRUG DELIVERY (2016)
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Eli L. Diamond et al.
CANCER DISCOVERY (2016)
The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ‐dependent inhibition of the AKT pathway
Suzana Assad Kahn et al.
EMBO Molecular Medicine (2016)
Nebulizable colloidal nanoparticles co-encapsulating a COX-2 inhibitor and a herbal compound for treatment of lung cancer
Ramy Said-Elbahr et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Formulation of insulin-loaded N-trimethyl chitosan microparticles with improved efficacy for inhalation by supercritical fluid assisted atomization
Yu-Bin Shen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Development of controlled-release cisplatin dry powders for inhalation against lung cancers
Vincent Levet et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy
Remi Rosiere et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Synthesis and Characterization of Inhalable Flavonoid Nanoparticle for Lung Cancer Cell Targeting
Wing-Hin Lee et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma
Tian Luo et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging
Ahmed O. Elzoghby et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Poly(amidoamine) Dendrimer-Doxorubicin Conjugates: In Vitro Characteristics and Pseudosolution Formulation in Pressurized Metered-Dose Inhalers
Qian Zhong et al.
MOLECULAR PHARMACEUTICS (2016)
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
Peter T. Daley-Yates
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Nebulization as a delivery method for mAbs in respiratory diseases
Renaud Respaud et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy
Remi Rosiere et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity
Rania A. H. Ishak et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations
Leanne G. Ahronian et al.
CANCER DISCOVERY (2015)
Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
Wing-Hin Lee et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Gene Therapies for Cancer: Strategies, Challenges and Successes
Swadesh K. Das et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies
Samantha A. Meenach et al.
AAPS PHARMSCITECH (2014)
Delivery strategies for sustained drug release in the lungs
Cristina Loira-Pastoriza et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Recent advances in curcumin nanoformulation for cancer therapy
Wing-Hin Lee et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract
Salome Juliette Koussoroplis et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity
Sanna R. Rijpma et al.
MALARIA JOURNAL (2014)
Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations
Mehra Haghi et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies
Therese Ericsson et al.
XENOBIOTICA (2014)
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2014)
Nanoparticle diffusion in respiratory mucus from humans without lung disease
Benjamin S. Schuster et al.
BIOMATERIALS (2013)
Nanotechnology approaches for inhalation treatment of fibrosis
Ronak Savla et al.
JOURNAL OF DRUG TARGETING (2013)
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis et al.
ONCOLOGIST (2013)
New perspectives in nanomedicine
Andrew J. Thorley et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Magnetic core-shell nanoparticles for drug delivery by nebulization
Navin Kumar Verma et al.
JOURNAL OF NANOBIOTECHNOLOGY (2013)
Statins inhibit proliferation and cytotoxicity of a human leukemic natural killer cell line
Jon Crosbie et al.
BIOMARKER RESEARCH (2013)
Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case-control study
Thomas Broughton et al.
BMC GASTROENTEROLOGY (2012)
New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis
Christophe Duret et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Feasibility and effectiveness of inhaled carboplatin in NSCLC patients
Paul Zarogoulidis et al.
INVESTIGATIONAL NEW DRUGS (2012)
PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin
Brijeshkumar Patel et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers
Francesca Ungaro et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Formation, characterization, and fate of inhaled drug nanoparticles
Jian Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Itraconazole Inhibits Angiogenesis and Tumor Growth in Non-Small Cell Lung Cancer
Blake T. Aftab et al.
CANCER RESEARCH (2011)
Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation
Tobias Lebhardt et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Paclitaxel loaded PEG5000-DSPE micelles as pulmonary delivery platform: Formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation
Kanwaldeep K. Gill et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety Study
Etienne Lemarie et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2011)
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
Wilson H. Roa et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Autophagy as a target for anticancer therapy
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles
Mainara Rangel Rodrigues et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2011)
mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
Vanessa S. Rodrik-Outmezguine et al.
CANCER DISCOVERY (2011)
Biologically Targeted Cancer Therapy and Marginal Benefits: Are We Making Too Much of Too Little or Are We Achieving Too Little by Giving Too Much?
Tito Fojo et al.
CLINICAL CANCER RESEARCH (2010)
Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers
Ram R. Patlolla et al.
JOURNAL OF CONTROLLED RELEASE (2010)
In Vitro Aqueous Fluid-Capacity-Limited Dissolution Testing of Respirable Aerosol Drug Particles Generated from Inhaler Products
Deepika Arora et al.
PHARMACEUTICAL RESEARCH (2010)
Effect of Particle Shape on Dry Particle Inhalation: Study of Flowability, Aerosolization, and Deposition Properties
Meer Saiful Hassan et al.
AAPS PHARMSCITECH (2009)
Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel
Jose Hureaux et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
p53 Cooperates Berberine-Induced Growth Inhibition and Apoptosis of Non-Small Cell Human Lung Cancer Cells In Vitro and Tumor Xenograft Growth In Vivo
Santosh K. Katiyar et al.
MOLECULAR CARCINOGENESIS (2009)
Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery
Jean C. Sung et al.
PHARMACEUTICAL RESEARCH (2009)
Airflow and Nanoparticle Deposition in a 16-Generation Tracheobronchial Airway Model
Zhe Zhang et al.
ANNALS OF BIOMEDICAL ENGINEERING (2008)
Targeted Drug-Aerosol Delivery in the Human Respiratory System
C. Kleinstreuer et al.
Annual Review of Biomedical Engineering (2008)
Inhaled nanoparticles - A current review
Wei Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Aerosolized chemotherapy
Frederic Gagnadoux et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2008)
Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: Optimization by PEG size selection
Yu Seok Youn et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer
Shirish M. Gadgeel et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
The international epidemiology of lung cancer - Geographical distribution and secular trends
Danny R. Youlden et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung
Bart P. H. Wittgen et al.
CLINICAL CANCER RESEARCH (2007)
Phase I study of inhaled doxorubicin for patients with metastatic tumors to the lungs
Gregory A. Otterson et al.
CLINICAL CANCER RESEARCH (2007)
Simvastatin potentiates TNF-α-induced apoptosis through the down-regulation of NF-κB-dependent antiapoptotic gene products:: Role of IκBα kinase and TGF-β-activated kinase-1
Kwang Seok Ahn et al.
JOURNAL OF IMMUNOLOGY (2007)
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Samuel K. Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Statin use and risk of colorectal cancer
Patricia F. Coogan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma
H. Derendorf et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Role of target geometry in phagocytosis
JA Champion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549
SV Fulzele et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer
A Haynes et al.
PHARMACEUTICAL RESEARCH (2005)
Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions
H Yamamoto et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced pulmonary malignancies
CF Verschraegen et al.
CLINICAL CANCER RESEARCH (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Pulmonary absorption rate and bioavailability of drugs in vivo in rats:: Structure-absorption relationships and physicochemical profiling of inhaled drugs
A Tronde et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Trojan particles: Large porous carriers of nanoparticles for drug delivery
N Tsapis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms
GE Bertolesi et al.
MOLECULAR PHARMACOLOGY (2002)
Lung surfactant phospholipids inhibit the uptake of respirable microspheres by the alveolar macrophage NR8383
BG Jones et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT
YT Pham et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)